CREB1 and Alzheimer disease: Consequently, our study aims to investigate the neuroprotective effect of CILO and/or CGA against a scopolamine (SCOP)-induced classic AD-like amnesic model in mice, focusing on the cAMP/CREB/BDNF signaling pathway.